Next Science (ASX:NXS) Other Cash Receipts from Operating Activities : A$-2.74 Mil (TTM As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Next Science Other Cash Receipts from Operating Activities?

Next Science's Other Cash Receipts from Operating Activities for the six months ended in Dec. 2023 was A$-2.83 Mil.

Next Science's Other Cash Receipts from Operating Activities for the trailing twelve months (TTM) ended in Dec. 2023 was A$-2.74 Mil.

Next Science Other Cash Receipts from Operating Activities Historical Data

The historical data trend for Next Science's Other Cash Receipts from Operating Activities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Next Science Other Cash Receipts from Operating Activities Chart

Next Science Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Cash Receipts from Operating Activities

Get a 7-Day Free Trial

-3.85

-4.14

-2.34

-3.01

-2.85

Next Science Semi-Annual Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Cash Receipts from Operating Activities	Get a 7-Day Free Trial					-2.13	0.04	-3.01	0.08	-2.83

Next Science Other Cash Receipts from Operating Activities Calculation

A company's cash flow from operations for a time period can be determined using either the direct or indirect method. The indirect method modifies the operating section from accrual accounting to a cash basis by taking the net income generated in a period and adding or subtracting changes in the asset and liability accounts to determine the implied cash flow. However, the direct method uses actual cash inflows and outflows from the company's operations directly. Other Cash Receipts from Operating Activities represents cash flow received from other operating activities in the direct cash flow method.

GuruFocus lists following items in "Cash Receipts from Operating Activities" section for non-financial companies:
Receipts from Customers
Receipts from Government Grants
Other Cash Receipts from Operating Activities

Other Cash Receipts from Operating Activities for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-2.74 Mil.

Next Science Other Cash Receipts from Operating Activities Related Terms

Thank you for viewing the detailed overview of Next Science's Other Cash Receipts from Operating Activities provided by GuruFocus.com. Please click on the following links to see related term pages.

Next Science (ASX:NXS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Next Science Ltd (ASX:NXS) » Definitions » Other Cash Receipts from Operating Activities

Comparable Companies

Traded in Other Exchanges

NXSCF:USA

Address

821 Pacific Highway, Suite 1902, Level 19, Tower A, The Zenith Building, Chatswood, NSW, AUS, 2067

Website

https://www.nextscience.com

Next Science Ltd is a medical technology company. It is engaged in the development and commercialization of its proprietary Xbio technology to reduce the impact of biofilm-based infections in human health. Xbio is a non-toxic technology with proven efficacy in eradicating both biofilm based and free-floating bacteria. Its products include Bactisure, SURGX, XEPERIENCE and BLASTX. The company derives revenue from the U.S. and Australia, of which prime revenue is derived from the U.S.

Next Science (ASX:NXS) Headlines

No Headlines